| XDR | Extensive drug-resistant |
| MDR | Multidrug-resistant |
| BLAs | β-lactam antibiotics |
| PBPs | Penicillin-binding proteins |
| ESBLs | Extended-spectrum β-lactamases |
| BLI | β-lactamases inhibitor |
| BLA | β-lactam antibiotic |
| MICs | Minimum inhibitory concentrations |
| LB | Luria–Bertani |
| RLU | Relative light units |
| DDW | Double-distilled water |
| IC50 | 50% inhibitory concentrations |
| PDA | Potato Dextrose agar |
| GPY | Glucose Peptone Yeast |
| ASW | Artificial seawater |
| cUTI | Complicated urinary tract |
| cIAI | Complicated intra-abdominal infections |
| HAP | Hospital-acquired pneumonia |
| VAP | Ventilator-associated pneumonia |
| HTS | High-throughput screening |
| NMR | Nuclear magnetic resonance |
| FBDD | Fragment-based drug discovery |